1. Home
  2. NHC vs NVCR Comparison

NHC vs NVCR Comparison

Compare NHC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NHC
  • NVCR
  • Stock Information
  • Founded
  • NHC 1971
  • NVCR 2000
  • Country
  • NHC United States
  • NVCR Switzerland
  • Employees
  • NHC N/A
  • NVCR N/A
  • Industry
  • NHC Hospital/Nursing Management
  • NVCR Medical/Dental Instruments
  • Sector
  • NHC Health Care
  • NVCR Health Care
  • Exchange
  • NHC Nasdaq
  • NVCR Nasdaq
  • Market Cap
  • NHC 1.6B
  • NVCR 1.4B
  • IPO Year
  • NHC N/A
  • NVCR 2015
  • Fundamental
  • Price
  • NHC $112.26
  • NVCR $11.91
  • Analyst Decision
  • NHC
  • NVCR Buy
  • Analyst Count
  • NHC 0
  • NVCR 7
  • Target Price
  • NHC N/A
  • NVCR $28.79
  • AVG Volume (30 Days)
  • NHC 45.2K
  • NVCR 1.7M
  • Earning Date
  • NHC 08-08-2025
  • NVCR 07-24-2025
  • Dividend Yield
  • NHC 2.30%
  • NVCR N/A
  • EPS Growth
  • NHC 12.96
  • NVCR N/A
  • EPS
  • NHC 6.70
  • NVCR N/A
  • Revenue
  • NHC $1,458,155,000.00
  • NVCR $630,160,000.00
  • Revenue This Year
  • NHC N/A
  • NVCR $6.68
  • Revenue Next Year
  • NHC N/A
  • NVCR $7.01
  • P/E Ratio
  • NHC $16.63
  • NVCR N/A
  • Revenue Growth
  • NHC 24.46
  • NVCR 14.58
  • 52 Week Low
  • NHC $89.14
  • NVCR $10.87
  • 52 Week High
  • NHC $137.53
  • NVCR $34.13
  • Technical
  • Relative Strength Index (RSI)
  • NHC 66.75
  • NVCR 42.42
  • Support Level
  • NHC $110.83
  • NVCR $11.63
  • Resistance Level
  • NHC $115.33
  • NVCR $12.47
  • Average True Range (ATR)
  • NHC 2.71
  • NVCR 0.47
  • MACD
  • NHC 0.87
  • NVCR 0.24
  • Stochastic Oscillator
  • NHC 83.26
  • NVCR 65.00

About NHC National HealthCare Corporation

National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: